[4-(2H-1,2,3-Benzotriazol-2-yl)phenoxy]alkanoic Acids as agonist of Peroxisome Proliferator-Activated Receptors (PPARs)

Chemistry and Biodiversity

Volumn 3, Issue 4, 2006, Pages 385-395

  Sparatore, Anna ^a   Godio, Cristina ^a   Perrino, Elena ^a   Romeo, Sergio ^a   Staels, Bart ^b   Fruchart, Jean Charles ^b   Crestani, Maurizio ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2H 1,2,3 BENZOTRIAZOL 2 YL) 2,6 DIMETHYLPHENOXY] 2 METHYLPROPANOIC ACID; 2 [4 (2H 1,2,3 BENZOTRIAZOL 2 YL)PHENOXY] 2 METHYLPROPANOIC ACID; 2 [4 (5 CHLORO 2H 1,2,3 BENZOTRIAZOL 2 YL)PHENOXY] 2 METHYLPROPANOIC ACID; 2 [4 (5 METHOXY 2H 1,2,3 BENZOTRIAZOL 2 YL)PHENOXY] 2 METHYLPROPANOIC ACID; 2 METHYL 2 [4 (5 METHYL 2H 1,2,3 BENZOTRIAZOL 2 YL)PHENOXY]PROPANOIC ACID; 2,2 DIMETHYL 3 [4 (5 METHYL 2H 1,2,3 BENZOTRIAZOL 2 YL)PHENOXY]PROPANOIC ACID; 2,2 DIMETHYL 5 [4 (5 METHYL 2H 1,2,3 BENZOTRIAZOL 2 YL)PHENOXY]PENTANOIC ACID; 3 [4 (2H 1,2,3 BENZOTRIAZOL 2 YL)PHENOXY] 2,2 DIMETHYLPROPANOIC ACID; 3 [4 (5 CHLORO 2H 1,2,3 BENZOTRIAZOL 2 YL)PHENOXY] 2,2 DIMETHYLPROPANOIC ACID; 3 [4 (5 METHOXY 2H 1,2,3 BENZOTRIAZOL 2 YL)PHENOXY] 2,2 DIMETHYLPROPANOIC ACID; 5 [4 (2H 1,2,3 BENZOTRIAZOL 2 YL)PHENOXY] 2,2 DIMETHYLPENTANOIC ACID; 5 [4 (5 CHLORO 2H 1,2,3 BENZOTRIAZOL 2 YL)PHENOXY] 2,2 DIMETHYLPENTANOIC ACID; 5 [4 (5 METHOXY 2H 1,2,3 BENZOTRIAZOL 2 YL)PHENOXY] 2,2 DIMETHYLPENTANOIC ACID; [2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; [4 (2H 1,2,3 BENZOTRIAZOL 2 YL)PHENOXY]ALKANOIC ACID DERIVATIVE; ANTILIPEMIC AGENT; BEZAFIBRATE; CLOFIBRATE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIRINIXIC ACID; ROSIGLITAZONE; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; DYSLIPIDEMIA; HUMAN; HUMAN CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; STRUCTURE ACTIVITY RELATION;

ANTILIPEMIC AGENTS; CELL LINE, TUMOR; HUMANS; HYPOLIPIDEMIC AGENTS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; TRIAZOLES;

EID: 33646262064     PISSN: 16121872     EISSN: 16121880     Source Type: Journal    
DOI: 10.1002/cbdv.200690042     Document Type: Article

References (24)

1. T. M. Willson, P. J. Brown, D. D. Sternbach, B. R. Henke, J. Med. Chem. 2000, 43, 527.
2. V. J. Ram, Prog. Drug Res. 2003, 60, 93.
3. B. Staels, J. Auwerx, Curr. Pharm. Des. 1997, 3, 1.
4. B. Staels, I Dallongeville, J. Auwerx, K Schoonjans, E. Leitersdorf, J. C. Fruchart, Circulation 1998, 98, 2088.
5. M. F. Linton, S. Fazio, Curr Atheroscler. Rep. 2000, 2, 29.
6. J. M. Lehmann, L. B. Moore, T. A. Smith-Oliver, W. O. Wilkinson, T. M. Willson, S. A. Kliewer, J. Biol. Chem. 1995, 270, 12953.
7. T. M. Willson, J. E. Cobb, D. J. Cowan, R. W. Wiethe, J. D. Correa, S. R. Prakash, K. D. Beck, L. B. Moore, S. A. Kliewer, J. M. Lehmann, J. Med. Chem. 1996, 39, 665.
8. B. M. Spiegelman, Diabetes 1998, 47, 507.
9. G. J. Murphy, J. C. Holder, Trends Pharmacol. Sci. 2000, 21, 469.
10. W. R. Oliver, J. L. Shenk, M. R. Snaith, C. S. Russel, K. D. Plunket, N. L. Bodkin, M. C. Lewis, D. A. Vinegar, M. L. Szaidman, M. H. Lambert, N. E. Xu, L. D. Sternbach, S. A. Kliewer, B. C. Hausen, T. M. Willson, Proc. Natl. Acad. Sci. U S.A. 2001, 98, 5306.
11. B. R. Henke, J. Med. Chem. 2004, 47, 4118.
12. P. Sauerberg, P. S. Bury, J. P. Magensen, H. J. Deussen, I. Pettersson, J. Fleckner, J. Nehlin, K. S. Frederiksen, T. Albrektsen, N. Din, L. A. Svensson, L. Ynddal, E. M. Wulff, L. Jeppesen, J. Med. Chem. 2003, 46, 4883.
13. A. Sparatore, F. Sparatore, Farmaco 1998, 53, 102.
14. G. Bargellini, Gazz. Chim. Ital. 1906, 36 II, 326.
15. P. Galimberti, A. Defranceschi, Gazz. Chim. Ital. 1947, 77, 431.
16. M. Crestani, D. Stroup, J. Y. L. Chiang, J. Lipid Res. 1995, 36, 2419.
17. A. A. Santilli, A. C. Scotese, R. M. Tomarelli, Experientia 1974, 30, 1110.
18. J. K. Reddy, D. E. Moody, D. L. Azarnoff, R. M. Tomarelli, Arch. Int. Pharmacodyn. 1977, 225, 51.
19. B. C. C. Cantello, M. A. Cawthorne, G. P. Cottam, P. T. Duff, D. Haigh, R. M. Hindley, C. A. Lister, S. A. Smith, P. L. Thurlby, J. Med. Chem. 1994, 37, 3977.
20. H. E. Xu, M. H. Lambert, V. G. Montana, K. D. Plunket, L. B. Moore, J. L. Collins, J. A. Oplinger, S. A. Kliever, R. T. Gampe, D. D. McKee, J. T. Moore, T. M. Willson, Proc. Natl. Acad. U.S.A. 2001, 98, 13919.
21. G. Irick, C. A. Kelly, J. C. Martin, US Patent 4070337, 1978; Chem. Abstr. 1978, 88, 137460.
22. Chem. Abstr. 1978, 88, 137460.
23. E. Raspe, L. Madsen, A.-M. Lefebvre, I. Leitersdorf, L. Gelman, J. Peinado-Onsurbe, J. Dallongeville, J.-C. Fruchart, R. Berge, B. Staels, J. Lipid Res. 1999, 40, 2099.
24. T. Hollons, F. K. Yoshimura, AnaL Biochem. 1989, 182, 411.